Fenistil contains penciclovir, which has demonstrable in vivo and in vitro activity against herpes simplex viruses (types 1 and 2) and varicella zoster virus. In virus-infected cells penciclovir is rapidly and efficiently converted into a triphosphate (mediated via virus-induced thymidine kinase)
Treatment of herpes simplex virus infections of the lips and face (herpes labialis) in adults and children over 12 years of age